{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:48:26Z","timestamp":1787806106946,"version":"build-2784847793"},"publisher-location":"Boston, MA","reference-count":18,"publisher":"Springer US","isbn-type":[{"value":"9781461372035","type":"print"},{"value":"9781461548577","type":"electronic"}],"license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-1-4615-4857-7_21","type":"book-chapter","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T15:44:47Z","timestamp":1318952687000},"page":"147-152","source":"Crossref","is-referenced-by-count":40,"title":["Polymorphisms of the Xenobiotic-Metabolizing Enzymes CYP1A1 and NAT-2 in Systemic Sclerosis and Lupus Erythematosus"],"prefix":"10.1007","author":[{"given":"Sherko","family":"von Schmiedeberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"R\u00f6nnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Specker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Golka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Richter-Hintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-C.","family":"Schuppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gleichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1093\/carcin\/15.12.2961","volume":"15","author":"F Crofts","year":"1994","unstructured":"Crofts F., Taiolo E., Trachman J., Cosma c.n., Currie D., Toniolo P., Garte S.J.: Functional significance of different human CYP1 A1 genotypes. Carcinogenesis 15: 2961\u20132963 (1994).","journal-title":"Carcinogenesis"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/BF00195139","volume":"73","author":"AK Daly","year":"1995","unstructured":"Daly A.K.: Molecular basis of polymorphic drug metabolism. J Mol Med 73: 539\u2013553 (1995).","journal-title":"J Mol Med"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00003088-199426010-00005","volume":"26","author":"FJ Gonzalez","year":"1994","unstructured":"Gonzalez F.J., Idle J.R.: Pharmacogenetic phenotyping and genotyping. Present status and future potential. Clin Pharmacokinet 26: 59\u201370 (1994).","journal-title":"Clin Pharmacokinet"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/clpt.1983.45","volume":"33","author":"DM Grant","year":"1983","unstructured":"Grant D.M., Tang B.K., Kalow W.: Polymorphic N-acetylation of a caffeine metabolite. Clin Pharmacol Ther 33: 355\u2013359 (1983).","journal-title":"Clin Pharmacol Ther"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/eji.1830260202","volume":"26","author":"P Griem","year":"1996","unstructured":"Griem P., Panthel K., Kalbacher H., Gleichmann E.: Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides. Eur J Immunol 26: 279\u2013287 (1996).","journal-title":"Eur J Immunol"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/oxfordjournals.jbchem.a123594","volume":"110","author":"S Hayashi","year":"1990","unstructured":"Hayashi S., Watanabe J., Nakachi K., Kawajiri K.: Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the haeme binding region of the human cytochrome P450IA1 gene. J Biochem 110: 407\u2013411(1990).","journal-title":"J Biochem"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1349-7006.1996.tb00194.x","volume":"87","author":"C Kiyohara","year":"1996","unstructured":"Kiyohara C, Hirohata T., Inutsuka S.: The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1 A1 gene. Jpn J Cancer Res 87: 18\u201324(1996).","journal-title":"Jpn J Cancer Res"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/clpt.1990.137","volume":"48","author":"CR Kumana","year":"1990","unstructured":"Kumana C.R., Chan M.Y., Wong K.-L., Wong W.S., Kou M., Lauder I.J.: Lack of association between slow acetylator status and spontaneous lupus erythematosus. Clin Pharmacol Ther 48: 208\u2013213 (1990).","journal-title":"Clin Pharmacol Ther"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/art.1780391023","volume":"39","author":"W Ollier","year":"1996","unstructured":"Ollier W., Davies E., Snowden N., Alldersea J., Freyer A., Jones P., Strange R.: Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Rp+\/La\u2212 autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum 39: 1763\u20131764(1996).","journal-title":"Arthritis Rheum"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00409407","volume":"67","author":"T Oyama","year":"1995","unstructured":"Oyama T., Mitsudomi T., Kawamoto T., Ogami A., Osaki T., Kodama Y, Yasumoto K.: Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 67: 253\u2013256 (1995).","journal-title":"Int Arch Occup Environ Health"},{"key":"21_CR11","first-page":"262","volume":"11","author":"PJ Rush","year":"1984","unstructured":"Rush P.J., Bell M.J., Farn A.G.: Toxic oil syndrome (Spanish oil disease) and chemically induced scleroderma-like conditions. J Rheumatol 11: 262\u2013264 (1984).","journal-title":"J Rheumatol"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1126\/science.7725110","volume":"268","author":"S Schmiedeberg Von","year":"1995","unstructured":"Von Schmiedeberg S., Goebel C, Gleichmann E., Uetrecht J.P.: Neutrophils and drug metabolism. Science 268: 585\u2013586(1995).","journal-title":"Science"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0167-5699(95)80133-2","volume":"16","author":"AN Theofilopoulos","year":"1995","unstructured":"Theofilopoulos A.N.: The basis of autoimmunity Part II: Genetic predisposition. Immunol Today 16: 150\u2013159(1995).","journal-title":"Immunol Today"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2165\/00003088-198106020-00003","volume":"6","author":"JP Uetrecht","year":"1981","unstructured":"Uetrecht J.P., Woosley R.L.: Acetylator phenotype and lupus erythematosus. Clin Pharmacokinet 6: 118\u2013134(1981).","journal-title":"Clin Pharmacokinet"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/03602539208996297","volume":"24","author":"JP Uetrecht","year":"1992","unstructured":"Uetrecht J.P.: The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metabolism Rev 24: 299\u2013366 (1992).","journal-title":"Drug Metabolism Rev"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1073\/pnas.88.14.6333","volume":"88","author":"KP Vatsis","year":"1991","unstructured":"Vatsis K.P., Martell K.J., Weber W.W.: Diverse point mutations in the human gene for polymorphic N-ace-tyltransferase. Proc Natl Acad Sci USA 88: 6333\u20136337 (1991).","journal-title":"Proc Natl Acad Sci USA"},{"key":"21_CR17","first-page":"746","volume":"73","author":"RL Young","year":"1995","unstructured":"Young R.L., Johnson K.J., Richardson B.C.: Biology of disease: New concepts in the pathogenesis of druginduced Lupus. Lab Invest 73: 746\u2013759 (1995).","journal-title":"Lab Invest"},{"key":"21_CR18","first-page":"172","volume-title":"Occupational skin disease","author":"E Zuschunke","year":"1990","unstructured":"Zuschunke E., Ziegler V., Haustein U.-F.: Occupational induced connective tissue disorders. In.: Adams RM (Ed.): Occupational skin disease. Philadelphia-London, WB Saunderss Comp. pp 172\u2013183 (1990)."}],"container-title":["Advances in Experimental Medicine and Biology","Rheumaderm"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-4857-7_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T21:41:48Z","timestamp":1558129308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-4857-7_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9781461372035","9781461548577"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-4857-7_21","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1999]]}}}